Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,053.6
-69.7 (-2.23%)

 

  • STI Straits Times Index
    3,053.6
    -69.7 (-2.23%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,582.5
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,027.6
    308.9 (1.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,490.4
    60.8 (1.77%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,084.5
    636.5 (2.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,975.8
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,144.3M
  • Value: 2,909.7M
  • Rise: 55
  • Fall: 394
  • Unch: 323

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.007-0.002
Sembcorp Marine0.179-0.012
Oceanus^0.034-0.002
Genting Sing0.785-0.025
YZJ Shipbldg SGD1.410-0.050
Golden Agri-Res0.250-0.025
Singtel2.320-0.090
ThaiBev0.665-0.030
Renaissance United0.004+0.001
Jiutian Chemical0.092-0.006

World Indices

World Indices
Name Last Change
Nasdaq 13,125.0 +93.3
HSI 28,027.6 +308.9
HSCEI 10,405.0 +65.0
Jakarta 5,975.8
Nikkei 225 28,084.5 +636.5
SSE Comp 3,490.4 +60.8
Shanghai A 3,658.5 +63.8
Shanghai B 250.2 +2.5
KOSPI 3,153.3 +31.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NUVATION BIO INC NUVATION BIO INC CLASS A
Updated on 13 May 2021 (End of trading day)
Last (USD): 10.970 Change: -0.070 High: 11.550 Remarks: -
Change (%): -0.63 Low: 10.910
Open 11.160 Yesterday's Close 11.040000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 429,264 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.01403 Trailing EPS (USD) e -0.01403 NAV (USD) b 0.6534
PE a - Trailing PE f - Price / NAV b 16.7891
Dividend (USD) d - Cash In Hand (USD) g 0.0042 Issued & Paid-up Shares c 216,650,000
Dividend Yield (%) d - Price / Cash In Hand g 2,611.905 Treasury Shares h -
Market Cap (M) 2,387.620 Enterprise Value (M) 2,386.713
Piotroski F Score - Exchange Code NUVB Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 72.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 11 Feb 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NUVATION BIO INC NYSE 2,387.620 - - 16.7891 -
Industry Biotechnology NYSE 1,331.248 55.281 158.853 7.6616 -
Local Peer ARCUS BIOSCIENCES INC NYSE 1,963.037 - - 2.9529 -
Local Peer MYOVANT SCIENCES LTD NYSE 1,847.204 - - - -
Local Peer SQZ BIOTECHNOLOGIES CO NYSE 315.621 - - - -
Local Peer ENZO BIOCHEM INC NYSE 142.757 - - 2.3103 -
Global Peer AMGEN INC NASDAQ 144,827.827 19.938 20.441 15.5162 2.556
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 126,300.351 40.270 33.186 11.9520 1.057
Global Peer GILEAD SCIENCES INC NASDAQ 86,425.544 702.661 287.128 4.5602 3.947
Global Peer MODERNA INC NASDAQ 60,177.001 - 100.603 15.6792 -
Global Peer WUXI BIO HKEx 439,596.059 231.634 231.636 18.0296 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,487.927 20.463 20.090 6.1789 -
Global Peer ILLUMINA INC NASDAQ 54,523.700 83.115 86.546 11.0776 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 55,101.345 15.684 13.762 4.6006 -
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 43,664.582 2,520.424 30.041 14.7451 -
Other Global Peers BIOGEN INC (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ZAI LAB-SB (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), EXELIXIS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), GENSCRIPT BIO (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), JOINN (HKEx), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), Lonza (SGX), TWIST BIOSCIENCE CORPORATION (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), KINTOR PHARMA-B (HKEx), ARVINAS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), AMICUS THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), ALPHAMAB-B (HKEx), KYMERA THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), FIBROGEN INC (NASDAQ), INSTIL BIO INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), JACOBIO-B (HKEx), MORPHIC HOLDING INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OCUGEN INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VIVA BIOTECH (HKEx), KURA ONCOLOGY INC (NASDAQ), BIOATLA INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), HAOHAI BIOTEC (HKEx), IMMUNOVANT INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), CURIS INC (NASDAQ), REGENXBIO INC (NASDAQ), ALLOVIR INC (NASDAQ), UNIQURE N.V. (NASDAQ), ASCENTAGE-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), JW THERAP-B (HKEx), PRECIGEN INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), ALECTOR INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), POLYNOVO LIMITED (ASX), STOKE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), PROTAGONIST THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), AFFIMED N V (NASDAQ), CORTEXYME INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), IMUGENE LIMITED (ASX), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), VAXCYTE INC (NASDAQ), JHBP-B (HKEx), TRILLIUM THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), EPIZYME INC (NASDAQ), MESOBLAST LTD (ASX), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), NKARTA INC (NASDAQ), PERSONALIS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), BIOXCEL THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AGENUS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), IMMATICS N V (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ARDELYX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), INHIBRX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), IVERIC BIO INC (NASDAQ), COMPUGEN (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), DPHARMA (Bursa), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), VERASTEM INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), ASCLETIS-B (HKEx), ANTEOTECH LIMITED (ASX), SINOMAB BIO-B (HKEx), CUE BIOPHARMA INC (NASDAQ), AKOUOS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ADICET BIO INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), GREENWICH LIFESCIENCES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SESEN BIO INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), ESSEX BIO-TECH (HKEx), SEELOS THERAPEUTICS INC (NASDAQ), ONCORUS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), OPTHEA LIMITED (ASX), AVROBIO INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), LAVA THERAPEUTICS NV (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), LEE'S PHARM (HKEx), PORTAGE BIOTECH INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), KAMADA LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), IMMUTEP LTD (ASX), TREVENA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CHIASMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), NANOVIRICIDES INC (NYSE American), CO DIAGNOSTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MEDICINOVA INC (NASDAQ), BIOVIE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CEL-SCI CORP (NYSE American), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), IMMUNOME INC (NASDAQ), SAVARA INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BIONOMICS LTD (ASX), SYNLOGIC INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EQUILLIUM INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOMX INC (NYSE American), IBIO INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), CATALYST BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), VASCULAR BIOGENICS LTD (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ORGENESIS INC (NASDAQ), LONGEVERON INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), APTEVO THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), METACRINE INC (NASDAQ), LEAF RESOURCES LTD (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), UNI-BIO GROUP (HKEx), CAPRICOR THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), RECRO PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), AIKIDO PHARMA INC (NASDAQ), COHBAR INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CELLECTAR BIOSCIENCES INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), ADVAXIS INC (NASDAQ), CT ENTERPRISE (HKEx), AZURRX BIOPHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), KIROMIC BIOPHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACORDA THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), PALISADE BIO INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), SOLIGENIX INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), HISTOGEN INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), GEOVAX LABS INC (NASDAQ), Suntar Eco-City (SGX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BIOSINO BIO-TEC (HKEx), ADALTA LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CRYOSITE (ASX), NANOLLOSE LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.580
-5.02 %
10 Days --0.220
-1.97 %
20 Days --0.380
-3.35 %
Medium Term Return 3 Months -+1.970
+21.89 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.560 - 15.075 Change From 1 Year Low +2.410 % Change From 1 Year Low (%) +28.15
Change From 1 Year High -4.105 % Change From 1 Year High (%) -27.23
2 Years Range 8.560 - 15.075 Change From 2 Years Low +2.410 % Change From 2 Years Low (%) +28.15
Change From 2 Years High -4.105 % Change From 2 Years High (%) -27.23
5 Years Range 8.560 - 15.075 Change From 5 Years Low +2.410 % Change From 5 Years Low (%) +28.15
Change From 5 Years High -4.105 % Change From 5 Years High (%) -27.23
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
13 May 2021 11.160 11.550 10.910 10.970 429,264 -
12 May 2021 10.750 11.085 10.710 11.040 312,605 -
11 May 2021 10.800 11.000 10.570 10.760 354,601 -
10 May 2021 11.440 11.465 10.990 11.030 407,249 -
07 May 2021 11.020 11.600 11.020 11.550 364,944 -
06 May 2021 11.190 11.500 10.880 11.020 410,092 -
05 May 2021 10.660 11.570 10.480 11.220 501,548 -
04 May 2021 10.720 10.720 10.240 10.630 377,487 -
03 May 2021 11.140 11.205 10.510 10.870 597,484 -
30 Apr 2021 11.570 11.750 11.160 11.190 288,025 -
29 Apr 2021 11.380 11.610 11.030 11.590 406,163 -
28 Apr 2021 11.000 11.580 10.930 11.330 543,099 -
27 Apr 2021 11.410 11.410 10.910 11.000 623,588 -
26 Apr 2021 11.250 11.650 11.250 11.320 371,178 -
23 Apr 2021 10.980 11.350 10.913 11.240 419,834 -
22 Apr 2021 10.700 11.030 10.350 10.780 496,756 -
21 Apr 2021 10.280 10.700 10.000 10.610 463,031 -
20 Apr 2021 11.020 11.250 10.140 10.240 506,324 -
19 Apr 2021 11.350 11.350 10.900 10.960 186,907 -
16 Apr 2021 11.860 11.890 11.280 11.350 252,898 -
15 Apr 2021 11.760 11.880 11.610 11.760 358,255 -
14 Apr 2021 11.170 11.990 11.030 11.570 645,255 -
Summary
Current 2 Weeks
(30 Apr 2021 to 13 May 2021)
11.570 11.750 10.240 10.970 4,043,299 -
Previous 2 Weeks
(16 Apr 2021 to 29 Apr 2021)
11.860 11.890 10.240 11.590 4,269,778 -
4 Weeks from
(18 Mar 2021 to 15 Apr 2021)
13.660 14.310 10.240 11.760 27,346,439 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.